HGHRX
Price
$33.21
Change
+$0.22 (+0.67%)
Updated
Jun 2 closing price
Net Assets
800.87M
SHSAX
Price
$60.57
Change
+$0.20 (+0.33%)
Updated
Jun 2 closing price
Net Assets
6.47B
Interact to see
Advertisement

HGHRX vs SHSAX

Header iconHGHRX vs SHSAX Comparison
Open Charts HGHRX vs SHSAXBanner chart's image
Hartford Healthcare R3
Price$33.21
Change+$0.22 (+0.67%)
VolumeN/A
Net Assets800.87M
BlackRock Health Sciences Opps Inv A
Price$60.57
Change+$0.20 (+0.33%)
VolumeN/A
Net Assets6.47B
HGHRX vs SHSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HGHRX vs. SHSAX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a Buy and SHSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 6.47B vs. HGHRX (801M). SHSAX pays higher dividends than HGHRX: SHSAX (0.23) vs HGHRX (0.00). HGHRX was incepted earlier than SHSAX: HGHRX (18 years) vs SHSAX (25 years). HGHRX (1.63) is less costly to investors than SHSAX (1.09). HGHRX is a more actively managed with annual turnover of: 40.00 vs. SHSAX (27.00). HGHRX has a lower initial minimum investment than SHSAX: HGHRX (0) vs SHSAX (1000). SHSAX annual gain was more profitable for investors over the last year : -13.42 vs. HGHRX (-15.86). SHSAX return over 5 years is better than : -9.84 vs. HGHRX (-18.62).
HGHRXSHSAXHGHRX / SHSAX
Total Expense Ratio1.631.09150%
Annual Report Gross Expense Ratio1.631.09150%
Fund Existence18 years25 years-
Gain YTD-6.913-3.315209%
Front LoadN/A5%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets801M6.47B12%
Annual Yield % from dividends0.000.23-
Returns for 1 year-15.86-13.42118%
Returns for 3 years-5.12-8.8458%
Returns for 5 years-18.62-9.84189%
Returns for 10 years-20.939.80-214%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USPFX30.03N/A
N/A
Union Street Partners Value Advisor
APGAX97.03N/A
N/A
AB Large Cap Growth A
PWGIX24.29N/A
N/A
Impax US Sustainable Economy Instl
FARCX14.91N/A
N/A
Nuveen Real Estate Securities I
GAOZX21.00N/A
N/A
JPMorgan Global Allocation R6